tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Want to see NMRA full AI Analyst Report?

Neumora Therapeutics, Inc. (NMRA) Technical Analysis

431 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
0Neutral
11Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Neumora Therapeutics, Inc.’s (NMRA) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Neumora Therapeutics, Inc. is a Buy.
Neumora Therapeutics, Inc.’s (NMRA) 20-Day exponential moving average is 1.62, while Neumora Therapeutics, Inc.’s (NMRA) share price is $1.49, making it a Sell.
Neumora Therapeutics, Inc.’s (NMRA) 50-Day exponential moving average is 1.71, while Neumora Therapeutics, Inc.’s (NMRA) share price is $1.49, making it a Sell.

Neumora Therapeutics, Inc. (NMRA) Pivot Points

Aug 02, 2026, 04:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neumora Therapeutics, Inc. (NMRA) Moving Averages

Aug 02, 2026, 04:20 AM
Period
Simple
Exponential
MA5
1.65Sell
1.63Sell
MA10
1.61Buy
1.62Sell
MA20
1.62Sell
1.62Sell
MA50
1.65Sell
1.71Sell
MA100
1.96Sell
1.87Sell
MA200
2.18Sell
1.97Sell
Neumora Therapeutics, Inc.’s (NMRA) 10-Day exponential moving average is 1.62, while Neumora Therapeutics, Inc.’s (NMRA) share price is $1.49, making it a Sell.
Neumora Therapeutics, Inc.’s (NMRA) 100-Day exponential moving average is 1.87, while Neumora Therapeutics, Inc.’s (NMRA) share price is $1.49, making it a Sell.
Neumora Therapeutics, Inc.’s (NMRA) stock price is $1.49 and Neumora Therapeutics, Inc.’s (NMRA) 50-day simple moving average is 1.65, creating a Sell signal.
Neumora Therapeutics, Inc.’s (NMRA) stock price is $1.49 and Neumora Therapeutics, Inc.’s (NMRA) 100-day simple moving average is 1.96, creating a Sell signal.
Neumora Therapeutics, Inc.’s (NMRA) stock price is $1.49 and Neumora Therapeutics, Inc.’s (NMRA) 200-day simple moving average is 2.18, creating a Sell signal.

Neumora Therapeutics, Inc. (NMRA) Technical Indicators

Aug 02, 2026, 04:20 AM
Name
Value
Implied Action
RSI (14)
42.04
Neutral
STOCH (9,6)
18.06
Buy
STOCHRSI (14)
11.70
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
8.96
Buy
Williams %R
-92.21
Buy
CCI (14)
-207.05
Buy
ATR (14)
0.13
-
Ultimate Oscillator
38.54
Neutral
ROC
0.63
Buy
Neumora Therapeutics, Inc.’s (NMRA) Relative Strength Index (RSI) is 42.04, creating a Neutral signal.
Neumora Therapeutics, Inc.’s (NMRA) Trend Strength Indicator (ADX) is 8.96, creating a Buy signal.
Neumora Therapeutics, Inc.’s (NMRA) Commodity Channel Index (CCI) is -207.05, creating a Buy signal.
Neumora Therapeutics, Inc.’s (NMRA) Price Rate of Change (ROC) is 0.63, creating a Buy signal.

FAQ

Is NMRA a Buy, Hold, or Sell?
Based on NMRA’s technical indicators, NMRA is a Strong Sell.
    What is NMRA’s RSI (14)?
    NMRA’s RSI (14) is 42.04, which suggests NMRA is a Neutral.
      What is NMRA’s MACD?
      NMRA’s MACD is -0.03, which suggests NMRA is a Buy.
        What is NMRA’s 5-day moving average?
        NMRA’s 5-day moving average is 1.65, which suggests NMRA is a Sell.
          What is NMRA’s 20-day moving average?
          NMRA 20-day moving average is 1.62, which suggests NMRA is a Sell.
            What is NMRA’s 50-day moving average?
            NMRA’s 50-day moving average is 1.65, which suggests NMRA is a Sell.
              What is NMRA’s 200-day moving average?
              NMRA’s 200-day moving average is 2.18, which suggests NMRA is a Sell.
                What is NMRA’s Williams % R (14)?
                NMRA’s Williams % R (14) is -92.21, which suggests NMRA is a Buy.
                  What is NMRA’s CCI (14)?
                  NMRA’s CCI (14) is -207.05, which suggests NMRA is a Buy.